For investors seeking potential gains, one effective strategy is to identify stocks that are currently on an upward trajectory. These stocks, which show strong upward movement, often continue their positive trend for several trading sessions.
In this momentum watchlist, we’ll take a closer look at four such stocks that have recently seen solid gains, letting you decide if they’re worth adding to your watchlist.
On Friday, Ameritek Ventures Inc. (OTC: ATVK) closed at $0.0029 USD, for a 5.45% gain.
ATVK is an emerging technology company that focuses on cutting-edge industries such as robotic technology, artificial intelligence, and blockchain cloud software. Augmum, one of its standout subsidiaries, is a forerunner in the integration of augmented reality and machine learning.
Augmum’s innovative approach involves enhancing the control of robotic arms using specialized gloves and glasses. This technology has the potential to streamline various industries by automating tasks and increasing precision.
With the global robotic technology market projected to reach $283 billion by 2032 from $72 billion in 2022, Ameritek Ventures is strategically positioned to capitalize on this rapid growth.
In a recent development, Ameritek Ventures confirmed that its subsidiary, Augmum Inc., is actively working on HaliOas, augmented reality glasses integrated with artificial intelligence. These glasses are poised to serve critical functions in sectors such as medicine, construction, and the military by providing intuitive end-user information.
HaliOas is designed for all-day usability, offering a wide range of applications, including map navigation and an immersive augmented reality experience. Dr. Shaun Passley, CEO of Ameritek Ventures, expressed enthusiasm about HaliOas, emphasizing its affordability and quality as an AR solution.
The company’s commitment to accessibility is evident, as Augmum plans to offer the AI-powered AR headset at a competitive price point below $500, making it accessible to a broader audience.
In conclusion, Ameritek Ventures Inc. (OTC: ATVK) has demonstrated robust performance with its recent stock gain on Friday. With its innovative developments in robotics and augmented reality, ATVK is positioned to make a significant impact in these dynamic industries.
Astra Energy Inc. (OTC: ASRE) demonstrated a sturdy market performance, closing at $0.45 USD, marking a noteworthy gain of 6.90% on Friday. This positive price movement captured the attention of investors and added momentum to the company’s market presence.
Astra Energy Inc. is an integrated solutions provider specializing in investments and the development of clean and renewable energy projects. The company’s strategic focus lies in markets characterized by high demand, limited supply, and opportunities to address pressing market needs. Astra’s core strategy revolves around securing technologies and assets, identifying viable market opportunities, and skillfully leveraging resources, expertise, and technology to execute groundbreaking projects.
The company’s overarching goal is to build a more secure and sustainable power sector that not only aligns with its purpose, mission, and values but also helps to transform the economic, environmental, and social landscape for future generations.
In a press release dated August 21, 2023, Astra Energy Inc. recently disclosed a significant milestone accomplished by its subsidiary, Regreen Technologies Inc. Independent testing by Soil Control Lab, a state-approved team of analytical chemists and bacteriologists, confirmed Regreen’s ability to efficiently process municipal solid waste into a non-waste Class A compostable commodity.
This accomplishment is especially significant because it aligns with California Senate Bill 1383, a mandate aimed at reducing organic waste disposal in landfills by 2025. For municipal recovery facilities in California to comply with SB 1383 requirements, Regreen, an Astra Energy subsidiary, has demonstrated a workable solution with potential national applications.
The business model of the Regreen system entails both collecting tipping fees for waste processing and securing offtake agreements for the resulting commodity. Given the significant volume of municipal solid waste generated annually in the United States, as well as the significant revenue in waste management services, the Regreen Total Waste System offers compelling income potential.
Furthermore, this innovative technology has the potential to be sold or deployed on a global scale, providing Astra Energy Inc. with a variety of revenue streams. It also complies with US and international environmental regulations, solidifying its position as an important addition to Astra’s intellectual property portfolio.
In summary, ASRE showcased a strong market performance on Friday, September 1st. The company’s dedication to sustainability is further demonstrated by the recent milestone reached by its subsidiary, Regreen Technologies, which also highlights the company’s potential to have a significant impact on waste management and environmental sustainability.
Dalrada Financial Corporation (OTC: DFCO) exhibited an impressive performance in the market, closing at $0.28 USD, marking a substantial gain of 17.68%.
Dalrada Financial Corporation operates with a comprehensive portfolio spanning climate technology, clean energy, and precision manufacturing. Through a global network of ventures, Dalrada’s mission is to address distinct challenges across economic, environmental, and efficiency domains, delivering tangible value and notable returns on investment.
Dalrada’s subsidiaries and strategic partners are at the forefront of cutting-edge science, engineering, and technology that prioritize eco-sensitivity. By pioneering these initiatives across diverse industries, the company plays a pivotal role in reducing energy expenditures and dismantling barriers that hinder progress, leading the way toward a sustainable and prosperous future.
A recent development from Dalrada demonstrates their commitment to expanding their influence. On August 30, 2023, the company unveiled its latest venture, Dalrada Technologies Morocco. This subsidiary, deeply committed to sustainable practices, is poised to make significant advancements in advanced climate technologies.
Dalrada Technologies Morocco’s primary focus revolves around providing installation and ongoing support services for high-efficiency commercial heat pumps across the MENA region, with its main office located in Fes. Notably, the potential establishment of a building and manufacturing center for Dalrada heat pumps in Morocco is under consideration.
This strategic expansion comes at a time of remarkable growth for Dalrada as it takes assertive steps toward advancing clean energy and climate technologies, aligning with global sustainability goals, including the pursuit of Net Zero objectives.
Brian Bonar, the CEO and Founder of Dalrada, expressed enthusiasm for the Moroccan expansion, highlighting the profound opportunity to bring advanced carbon-reducing technology and support to regions where it is most needed. As Dalrada Technologies Morocco emerges on the scene, it is positioned to contribute significantly to Dalrada’s broader mission of providing innovative climate technology products and services that optimize energy resources, minimize environmental impact, and lower energy costs.
Dalrada Technologies Morocco embodies the principles synonymous with its parent company, emphasizing excellence in customer service, transparent solutions, and a commitment to addressing environmental challenges.
By presenting an array of energy-efficient products and services while continually crafting novel solutions for renewable energies, the subsidiary seeks to enhance energy performance, drive cost savings, and combat climate change.
For the last stock that performed on Friday, let’s take a look at a NASDAQ-listed stock, Celularity Inc. (NASDAQ: CELU). CELU demonstrated a strong performance in the market, closing at $0.36 USD, marking a notable gain of 11.05%.
Celularity Inc., headquartered in Florham Park, N.J., is a pioneering biotechnology company at the forefront of cellular and regenerative medicine. The main objective of the company is to create allogeneic cryopreserved off-the-shelf placental-derived cell therapies, including MLASCs, CAR T-cells (T-cells engineered with chimeric antigen receptors), and genetically altered and unaltered natural killer (NK) cells.
These therapeutic programs target a wide range of indications, spanning autoimmune, infectious, degenerative diseases, and cancer. Additionally, Celularity develops, manufactures, and commercializes innovative biomaterial products also derived from the postpartum placenta.
Celularity’s approach is rooted in harnessing the unique biology and ready availability of the placenta to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
In a significant development announced last week, on August 29, 2023, Celularity entered into a multi-year Research Collaboration Services Agreement with Regeneron Pharmaceuticals, Inc. (Regeneron). This collaboration underscores Celularity’s demonstrated expertise in cell therapy research and its commitment to advancing the field.
The primary goal of this collaboration is to conduct research on Regeneron’s targeted allogeneic gamma delta chimeric antigen receptor (CAR) T-cell therapy. This therapy is designed to enhance proliferation and potency against solid tumors. The research activities will be conducted at Celularity’s state-of-the-art facility located in Florham Park, N.J. While financial terms were not disclosed, this agreement represents a significant milestone for Celularity.
“We believe that this relationship paves the way for future industry collaborations leveraging our world-class cell therapy facilities and capabilities”, said Robert J. Hariri, M.D., Ph.D., Celularity’s CEO, Chairman, and Founder. “We have long admired the exceptional scientific legacy at Regeneron and welcome the opportunity to collaborate with a world leader in innovative medicines.”
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Ameritek Ventures Inc. to assist in the production and distribution of content. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.